Historical record - last NADAC effective date: 11/18/2020
Product Information
LEVETIRACETAM 100 MG/ML SOLN is a generic product labeled by Taro Pharmaceuticals U.S.A. Inc., priced at $0.0345 per ML under NDC 51672413609. Its NADAC has been published 367 times since Nov 28, 2013.
FDA first approved this application on Feb 10, 2009. Its Orange Book therapeutic-equivalence code is AA.
Strength
100 mg/mL
Manufacturer
Taro Pharmaceuticals U.S.A. Inc.NDC
51672413609
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
11/18/2020
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA078774FDA Approved
2/10/2009
TE Code
AA
On Market Since
2/10/2009
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM 100 MG/ML SOLN has been published 367 times since Nov 28, 2013, and over the history we have for it it has declined 41.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0345 per ML |
|---|---|
| All-time high | $0.0635 (Feb 12, 2014) |
| All-time low | $0.0321 (Sep 23, 2020) |
| Median price | $0.0407 |
| Average price | $0.0426 |
| Largest weekly change | +13.8% (Feb 21, 2018) |
| Weeks tracked | 367 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-41.9%
Last surveyed Dec 2, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Taro Pharmaceuticals U.S.A. Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levetiracetam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVETIRACETAM 100 MG/ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 100 MG/ML SOLN, manufactured by Taro Pharmaceuticals U.S.A. Inc., is $0.0345 per ML (NDC 51672413609), effective Dec 2, 2020.
How has the price of LEVETIRACETAM 100 MG/ML SOLN changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM 100 MG/ML SOLN has declined 41.9%. It has been tracked across 367 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 100 MG/ML SOLN?
Since Nov 28, 2013, the NADAC for LEVETIRACETAM 100 MG/ML SOLN has ranged from a low of $0.0321 (Sep 23, 2020) to a high of $0.0635 (Feb 12, 2014), with a median of $0.0407 per ML.
Are there cheaper alternatives to LEVETIRACETAM 100 MG/ML SOLN?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 100 MG/ML SOLN, is $0.0301 per ML — about 13% below LEVETIRACETAM 100 MG/ML SOLN.
Who manufactures LEVETIRACETAM 100 MG/ML SOLN?
LEVETIRACETAM 100 MG/ML SOLN (NDC 51672413609) is labeled by Taro Pharmaceuticals U.S.A. Inc., and CMS classifies it as a generic product.